|
ALLK | Allakos Inc. |
|
|
ALLK | Allakos Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.65 |
| Leverage | 41.54% |
| Market Cap | $ 111.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -177.7m |
| Margin | 455756.54% |
Allakos Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Redwood City, California.